36
Participants
Start Date
November 16, 2020
Primary Completion Date
February 9, 2021
Study Completion Date
August 13, 2021
abaloparatide-sMTS (Patheon)
single-dose administration of abaloparatide 300 μg applied to the thigh for 5 minutes
abaloparatide-sMTS (Kindeva)
single-dose administration of abaloparatide 300 μg applied to the thigh for 5 minutes
abaloparatide-sMTS (Patheon)
single-dose administration of abaloparatide 300 μg applied to the thigh for 4 minutes
abaloparatide-sMTS (Patheon)
single-dose administration of abaloparatide 300 μg applied to the thigh for 7 minutes
Medpace Clinical Pharmacology, Cincinnati
Collaborators (1)
Medpace, Inc.
INDUSTRY
Radius Health, Inc.
INDUSTRY